Mark Robertson designs and optimizes small-molecule modulators of endocytic targets using structure-activity, focused libraries, and prodrug strategies. He also develops scalable photochemical methods—including solar photooxygenations—for sustainable manufacturing of fine and pharmaceutical intermediates.